TOP STORIES

• REGULATORY Japan Approves Lenvima/Keytruda Pair, Opdivo Label Expansion
  December 27, 2021

• REGULATORY Japan Approves MSD’s Oral COVID-19 Drug Molnupiravir
  December 27, 2021

• REGULATORY Ronapreve Given to Nearly 37,000 People in Japan by November, Xevudy to 270: MHLW
  December 24, 2021

• REGULATORY Japan Seeks Additional Study for Aducanumab, Next Review Might Be Few Years Off
  December 23, 2021

• REGULATORY Gist of FY2022 Drug Pricing Reform
  December 22, 2021

• REGULATORY Japan Likely to Expand PMP Coverage for Add’l Indications, Set 4-Year Grace Period for Spillover Exclusion: 2022 Reform
  December 21, 2021

• COMMENTARY Japan Unlikely to Introduce Medical Fee Incentives for Hospital Formularies in FY2022 Reform
  December 20, 2021

• BUSINESS Astellas to Abolish Pay Structure for Sales Reps, Switching to Company-Wide System Next April
  December 20, 2021

• BUSINESS Pfizer Agrees to Supply Oral COVID-19 Drugs for 2 Million People in Japan
  December 20, 2021

• BUSINESS Biogen to Challenge European Rejection of Aducanumab
  December 20, 2021

• BUSINESS Moderna to Develop All Global Pipeline Assets in Japan without Delay: Local Chief
  December 17, 2021

• BUSINESS Shionogi Pharma Eyes 10 Billion Yen Sales in CDMO Business in FY2022
  December 17, 2021

• REGULATORY Japan Approves Moderna Vaccine for COVID-19 Booster
  December 16, 2021

• REGULATORY Japan Panel OKs Moderna COVID-19 Vaccine for Booster Use
  December 16, 2021

• REGULATORY Aducanumab Up for Japan Advisory Panel Review on December 22
  December 15, 2021

• REGULATORY MHLW Calls for Lifting of Shipment Restrictions for 130 Generic API/Specifications after Survey Finds YOY Rise in Supplies
  December 14, 2021

• BUSINESS Chugai Files Actemra for COVID-19 Pneumonia in Japan
  December 14, 2021

• REGULATORY METI to Dole Out Support for “Dual-Use” Production Bases to Boost Pandemic Preparedness
  December 13, 2021

• REGULATORY Fiscal Discipline for Drug Spending Could Be Discussed towards FY2023: MOF Budget Examiner
  December 10, 2021

• REGULATORY E Keppra Generics from 12 Firms to Join NHI Price List, Patanol and Velcade AGs Too
  December 9, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 86
• 87
• 88
• 89
• 90
• 91
• 92
• 93
• 94
• …
• Next ›
• 最終 »